Sales/Maturities of Investments

$7.07B

TTM · Period ending: Jun 30, 2026 · USD

VRTX Sales/Maturities of Investments

Latest reported$7.07Bperiod endingJun 30, 2026

VRTX TTM Sales/Maturities of Investments ($0.00 → $7.07B)

TTM Sales/Maturities of Investments

High-resolution chart · PNG

VRTX sales/maturities of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Sales/Maturities of Investments — Trailing twelve months (TTM) (USD)
Period ending	Sales/Maturities of Investments (USD)
Jun 30, 2026	7,070,800,000
Mar 31, 2026	6,484,900,000
Dec 31, 2025	5,913,400,000
Sep 30, 2025	6,265,800,000
Jun 30, 2025	6,048,800,000
Mar 31, 2025	5,392,700,000
Dec 31, 2024	4,465,600,000
Sep 30, 2024	3,223,500,000
Jun 30, 2024	2,442,400,000
Mar 31, 2024	1,594,700,000
Dec 31, 2023	934,200,000
Sep 30, 2023	1,200,200,000
Jun 30, 2023	1,062,600,000
Mar 31, 2023	840,300,000
Dec 31, 2022	920,000,000
Sep 30, 2022	483,067,000
Jun 30, 2022	520,329,000
Mar 31, 2022	510,928,000
Dec 31, 2021	499,300,000
Sep 30, 2021	928,028,000
Jun 30, 2021	757,911,000
Mar 31, 2021	795,800,000
Dec 31, 2020	809,909,000
Sep 30, 2020	529,729,000
Jun 30, 2020	615,422,000
Mar 31, 2020	595,923,000
Dec 31, 2019	570,860,000
Sep 30, 2019	498,315,000
Jun 30, 2019	489,255,000
Mar 31, 2019	444,329,000
Dec 31, 2018	431,576,000
Sep 30, 2018	430,471,000
Jun 30, 2018	371,360,000
Mar 31, 2018	365,186,000
Dec 31, 2017	369,214,000
Sep 30, 2017	469,332,000
Jun 30, 2017	594,128,000
Mar 31, 2017	724,782,000
Dec 31, 2016	757,562,000
Sep 30, 2016	798,234,000
Jun 30, 2016	658,034,000
Mar 31, 2016	827,193,000
Dec 31, 2015	1,067,443,000
Sep 30, 2015	1,159,126,000
Jun 30, 2015	1,498,457,000
Mar 31, 2015	1,552,817,000
Dec 31, 2014	1,557,938,000
Sep 30, 2014	1,709,334,000
Jun 30, 2014	2,318,595,000
Mar 31, 2014	2,294,304,000
Dec 31, 2013	2,348,295,000
Sep 30, 2013	2,268,974,000
Jun 30, 2013	1,696,645,000
Mar 31, 2013	1,614,475,000
Dec 31, 2012	1,367,927,000
Sep 30, 2012	1,034,231,000
Jun 30, 2012	730,199,000
Mar 31, 2012	663,665,000
Dec 31, 2011	1,016,040,000
Sep 30, 2011	1,228,138,000
Jun 30, 2011	1,554,694,000
Mar 31, 2011	1,636,894,000
Dec 31, 2010	1,284,806,000
Sep 30, 2010	1,250,814,000
Jun 30, 2010	960,947,000
Mar 31, 2010	798,531,000
Dec 31, 2009	788,263,000
Sep 30, 2009	700,111,000
Jun 30, 2009	688,733,000
Mar 31, 2009	572,476,000
Dec 31, 2008	427,648,000
Sep 30, 2008	394,150,000
Jun 30, 2008	422,662,000
Mar 31, 2008	543,784,000
Dec 31, 2007	755,620,000
Sep 30, 2007	642,161,000
Jun 30, 2007	556,476,000
Mar 31, 2007	456,468,000
Dec 31, 2006	302,438,000
Sep 30, 2006	321,970,000
Jun 30, 2006	272,805,000
Mar 31, 2006	266,430,000
Dec 31, 2005	243,410,000
Sep 30, 2005	247,503,000
Jun 30, 2005	244,295,000
Mar 31, 2005	279,825,000
Dec 31, 2004	292,351,000
Sep 30, 2004	396,157,000
Jun 30, 2004	345,298,000
Mar 31, 2004	239,835,000
Dec 31, 2003	354,508,000
Sep 30, 2003	318,363,000
Jun 30, 2003	447,143,000
Mar 31, 2003	648,531,000
Dec 31, 2002	728,037,000
Sep 30, 2002	872,843,000
Jun 30, 2002	1,215,814,000
Mar 31, 2002	1,251,687,000
Dec 31, 2001	1,176,186,000
Sep 30, 2001	1,787,085,000